Evidence map›Paper›PMID 31571152›Full record

ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2020

Treatment of radiation-induced myelopathy with bevacizumab.

G Cañedo, I Solis, C González-San Segundo, L Madero, A Lassaletta

Abstract readCase ReportsLetter
PubMed Publisher
In one paragraph

Article in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

G CañedoDepartment of Pediatric Hematology-Oncology, Hospital Infantil Universitario del Niño Jesús, Avenida Menendez Pelayo 65, 28009, Madrid, Spain.
I SolisDepartment of Radiology, Hospital Infantil Universitario del Niño Jesús, Madrid, Spain.
C González-San SegundoDepartment of Radiation Oncology, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
L MaderoDepartment of Pediatric Hematology-Oncology, Hospital Infantil Universitario del Niño Jesús, Avenida Menendez Pelayo 65, 28009, Madrid, Spain.
A LassalettaDepartment of Pediatric Hematology-Oncology, Hospital Infantil Universitario del Niño Jesús, Avenida Menendez Pelayo 65, 28009, Madrid, Spain. lassaalvaro@yahoo.com.ORCID http://orcid.org/0000-0003-2881-1473
Menéndez Pelayo International University · ESHospital General Universitario Gregorio Marañón · ESHospital Infantil Universitario Niño Jesús · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Adrenal Cortex HormonesAngiogenesis InhibitorsAntineoplastic Agents, ImmunologicalAstrocytomaBevacizumabChildFemaleHumansNecrosisRadiation InjuriesRadiotherapy, Intensity-ModulatedSpinal CordSpinal NeoplasmsTreatment OutcomeAdrenal Cortex HormonesAngiogenesis InhibitorsAntineoplastic Agents, ImmunologicalBevacizumabBevacizumabRadiation-induced myelopathyRadionecrosis

Identifiers

PMID31571152
OpenAlexW2977264542

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.